by Admin Neo Lumina | Jul 17, 2025 | Press Release
NeoLumina BioScience Preparing to Begin a Phase 2 Clinical Trial of Innovative Psilocybin-Based Therapy for Binge Eating Disorder VANCOUVER, BRITISH COLUMBIA / July 17, 2025 / NeoLumina BioScience Inc., a pioneering clinical-stage biopharmaceutical company dedicated...
by Admin Neo Lumina | Jul 17, 2025 | Press Release
NeoLumina BioScience to Initiate Strategic Collaboration for Novel Psilocin Delivery System to Advance Mental Health Treatment VANCOUVER, BRITISH COLUMBIA / July 17, 2025/ NeoLumina BioScience Inc., a pioneering clinical-stage biopharmaceutical company dedicated to...
by Admin Neo Lumina | May 21, 2025 | News
‘Thoughts of food consume everything:’ Why eating disorders are rising, and what to do about it Eating disorders and hospitalizations of teenage girls have both increased. Experts discuss treatment and solutions. Author of the article:Lori Culbert The...
by Admin Neo Lumina | May 15, 2025 | News
Dr. Gaetano Morello on NeoLumina’s Novel Therapy for Binge-Eating Disorder https://youtu.be/eacsykp2tNQ Join functional-medicine pioneer Dr. Gaetano Morello as he reveals why binge-eating disorder—responsible for the highest mortality rate among psychiatric...
by Admin Neo Lumina | Apr 22, 2024 | News
The Entourage Effect in Mushrooms: Natural psilocybin may outperform synthetic A new study from the Hebrew University-Hadassah Medical Center has indicated that natural psilocybin extracts may demonstrate superior efficacy to synthetic psilocybin extracts. Recent...
